Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s):  IPCIQ

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.


TSXV:IPCI.H - Post by User

Post by TechTargeton Nov 06, 2015 5:20pm
99 Views
Post# 24268391

TechTarget I @ $2.56 CDN or IPCI @ $1.89 USD Accumulate slow

TechTarget I @ $2.56 CDN or IPCI @ $1.89 USD Accumulate slowNo rush here and we might even see a nice dip for even better accumulation.  I tend to do that when I show up.  I have some clown troops that follow me around these boards!

Charts indicate some slow accumulation on no volume from the lows of $2.16 CDN.

It's been a rought ride for investors up to now!   The pipeline is strong.  The hype is non-existant.  

Found via a guy doing stock screening.  I'm not the only on on these "bull"boards that find good stocks!  LOL :-) 

From the long timers here, except for the horrid past performance (as indicated by the charts), what's not to love about this?

These guys are doing investor relations this past week but who's idea was it to send a CFO and not the Doctors/PhDs behind the company?   This isn't a finance stock, it's a biotech right? :-)
Bullboard Posts